Related Experiment Video
Updated: Aug 26, 2025
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.0K
Mitral valve stenosis in the current era: a changing landscape
Cristina Giannini1, Matteo Mazzola1, Nicola Riccardo Pugliese2
1Cardiac, Thoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|October 11, 2022
Summary
Degenerative mitral stenosis (DMS) from mitral annulus calcification is rising in developed nations. New diagnostic and catheter-based treatments offer hope for reducing DMS-related illness and death.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Medical Research
Background:
- Mitral stenosis causes transmitral flow obstruction due to mitral valve abnormalities.
- Rheumatic fever is the primary global cause, but degenerative mitral stenosis (DMS) from mitral annulus calcification (MAC) is increasing in developed countries.
- DMS and rheumatic mitral stenosis (RMS) differ significantly in pathophysiology, prognosis, and progression.
Purpose of the Study:
- To review current knowledge on the pathophysiology, diagnosis, and treatment of DMS and RMS.
- To highlight existing diagnostic and therapeutic strategies for degenerative mitral stenosis.
- To identify persisting uncertainties and future perspectives in managing DMS.
Main Methods:
- Review of current literature on mitral stenosis, focusing on degenerative and rheumatic causes.
- Analysis of differences in pathophysiology, prognosis, and disease progression between DMS and RMS.
- Evaluation of emerging diagnostic techniques and catheter-based interventions for DMS.
Main Results:
- Degenerative mitral stenosis (DMS) due to mitral annulus calcification (MAC) is a growing concern in aging populations.
- Limited robust evidence currently exists for the management of DMS.
- Advancements in diagnostics and catheter-based interventions are emerging as promising avenues.
Conclusions:
- DMS presents distinct challenges compared to RMS, necessitating tailored management strategies.
- New diagnostic tools and interventional therapies are poised to improve outcomes for DMS patients.
- Further research is crucial to address current uncertainties and optimize the treatment of degenerative mitral stenosis.
More Related Videos
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
16
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
01:22Mitral Stenosis I: Introduction
27
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
27
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
30
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
30
01:27Mitral Stenosis IV: Nursing Management
28
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
28
01:25Mitral Regurgitation III: Medical Management
25
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25
01:22Mitral Valve Prolapse II: Assessment and Management
38
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
38